MiMedx stuffed distributor channels and its CEO was convicted of securities fraud
MiMedx Group · Biomedical products (listed)
The case in brief
Visible before detection
Checks that could have surfaced it, on hindsight
Third-party confirmation
Would have confirmed with distributors whether they had to pay.
Can mislead when: Counterparties can collude or ignore requests. A non-response is logged as a gap, never as a pass.
Bank credits vs books
Would have matched revenue to cash collected from distributors.
Can mislead when: AA only sees the accounts the company links, so an undisclosed account stays invisible. Cash-heavy businesses and timing differences create false flags.
Governance signals
Would have flagged retaliation against whistleblowers.
Can mislead when: Private companies file late, so these signals are lagging. Kubr uses them to support other flags, not to prove anything alone.
Where Kubr services would have helped
Valuation context
Offered in India- C11 Would have flagged retaliation against whistleblowers.
Portfolio monitor
Offered in India- C1 Would have matched revenue to cash collected from distributors.
- C11 Would have flagged retaliation against whistleblowers.
Borrower monitor
Offered in India- C1 Would have matched revenue to cash collected from distributors.
- C11 Would have flagged retaliation against whistleblowers.
Verified Snapshot
Offered in India- C11 Would have flagged retaliation against whistleblowers.
Mapped from the checks each service runs. A hindsight reading of public records, not a promise that the failure would have been found.
Same pattern
A summary of public documents. It reports what the sources say. It is not Kubr's finding and not a statement of guilt.